PRICE T ROWE ASSOCIATES INC /MD/

Position in IVVD — Invivyd, Inc.

CIK 80255 BALTIMORE, MD

Position in IVVD

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$150,590

+$128,982 QoQ

Shares Held

172,695

+383.5% QoQ

Ownership

0.059%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#50

of 124 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. IVVD ranks #267 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,678,047	$2,484,611,664
2	REGN	Regeneron Pharmaceuticals, Inc.	1,529,709	$953,834,749
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,728,421	$858,558,562
4	KYMR	Kymera Therapeutics, Inc.	7,112,980	$815,645,416
5	RPRX	Royalty Pharma plc	11,193,657	$627,628,347
6	RVMD	Revolution Medicines, Inc.	2,969,853	$447,655,945
7	MRNA	Moderna, Inc.	5,589,560	$391,436,886
8	TWST	Twist Bioscience Corp	3,634,652	$373,932,997

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$150,590	172,695	+383.5%	Shares	Defined	2026-08-14
2025-03-31	$21,608	35,716	+38.6%	Shares	Defined	2025-05-14
2024-12-31	$11,411	25,760	0.0%	Shares	Defined	2025-02-14
2024-09-30	$26,275	25,760	0.0%	Shares	Defined	2024-11-14
2024-06-30	$28,336	25,760	-44.8%	Shares	Defined	2024-08-14
2023-03-31	$55,966	46,639	-90.9%	Shares	Defined	2023-05-15
2022-12-31	$769,804	513,203	-10.4%	Shares	Sole	2023-02-14
2022-09-30	$1,791,780	572,454	+9.9%	Shares	Sole	2022-11-14
2022-06-30	$1,708,712	520,949	+4.0%	Shares	Sole	2022-08-15
2022-03-31	$2,284,856	501,065	+7.8%	Shares	Sole	2022-05-16
2021-12-31	$3,375,326	464,921	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.